Logo image of COV.PA

COVIVIO (COV.PA) Stock Fundamental Analysis

EPA:COV - Euronext Paris - Matif - FR0000064578 - REIT - Currency: EUR

51  +0.1 (+0.2%)

Fundamental Rating

4

Taking everything into account, COV scores 4 out of 10 in our fundamental rating. COV was compared to 42 industry peers in the Diversified REITs industry. While COV is still in line with the averages on profitability rating, there are concerns on its financial health. COV has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year COV was profitable.
In the past year COV had a positive cash flow from operations.
COV had positive earnings in 4 of the past 5 years.
Each year in the past 5 years COV had a positive operating cash flow.
COV.PA Yearly Net Income VS EBIT VS OCF VS FCFCOV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

1.2 Ratios

COV has a worse Return On Assets (0.27%) than 64.29% of its industry peers.
Looking at the Return On Equity, with a value of 0.83%, COV is doing worse than 64.29% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 3.14%, COV is in line with its industry, outperforming 42.86% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for COV is in line with the industry average of 3.74%.
The 3 year average ROIC (2.97%) for COV is below the current ROIC(3.14%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.27%
ROE 0.83%
ROIC 3.14%
ROA(3y)-1.05%
ROA(5y)0.29%
ROE(3y)-3.48%
ROE(5y)0.76%
ROIC(3y)2.97%
ROIC(5y)2.68%
COV.PA Yearly ROA, ROE, ROICCOV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

COV's Profit Margin of 5.23% is on the low side compared to the rest of the industry. COV is outperformed by 64.29% of its industry peers.
In the last couple of years the Profit Margin of COV has declined.
COV has a Operating Margin of 61.20%. This is in the lower half of the industry: COV underperforms 64.29% of its industry peers.
In the last couple of years the Operating Margin of COV has remained more or less at the same level.
Looking at the Gross Margin, with a value of 76.74%, COV is in line with its industry, outperforming 57.14% of the companies in the same industry.
COV's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 61.2%
PM (TTM) 5.23%
GM 76.74%
OM growth 3Y-1.46%
OM growth 5Y-1.11%
PM growth 3Y-61.53%
PM growth 5Y-38.78%
GM growth 3Y-2.18%
GM growth 5Y-0.89%
COV.PA Yearly Profit, Operating, Gross MarginsCOV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), COV is destroying value.
Compared to 1 year ago, COV has more shares outstanding
COV has more shares outstanding than it did 5 years ago.
The debt/assets ratio for COV has been reduced compared to a year ago.
COV.PA Yearly Shares OutstandingCOV.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
COV.PA Yearly Total Debt VS Total AssetsCOV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

COV has an Altman-Z score of 0.55. This is a bad value and indicates that COV is not financially healthy and even has some risk of bankruptcy.
COV's Altman-Z score of 0.55 is on the low side compared to the rest of the industry. COV is outperformed by 83.33% of its industry peers.
The Debt to FCF ratio of COV is 27.72, which is on the high side as it means it would take COV, 27.72 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of COV (27.72) is worse than 69.05% of its industry peers.
COV has a Debt/Equity ratio of 1.14. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.14, COV is doing worse than 80.95% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.14
Debt/FCF 27.72
Altman-Z 0.55
ROIC/WACC0.55
WACC5.71%
COV.PA Yearly LT Debt VS Equity VS FCFCOV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 0.96 indicates that COV may have some problems paying its short term obligations.
COV has a Current ratio of 0.96. This is in the better half of the industry: COV outperforms 69.05% of its industry peers.
COV has a Quick Ratio of 0.96. This is a bad value and indicates that COV is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of COV (0.85) is better than 69.05% of its industry peers.
Industry RankSector Rank
Current Ratio 0.96
Quick Ratio 0.85
COV.PA Yearly Current Assets VS Current LiabilitesCOV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 0.00% over the past year.
Measured over the past years, COV shows a decrease in Earnings Per Share. The EPS has been decreasing by -3.39% on average per year.
The Revenue has grown by 22.79% in the past year. This is a very strong growth!
Measured over the past years, COV shows a small growth in Revenue. The Revenue has been growing by 1.17% on average per year.
EPS 1Y (TTM)0%
EPS 3Y0.91%
EPS 5Y-3.39%
EPS Q2Q%5.69%
Revenue 1Y (TTM)22.79%
Revenue growth 3Y9.01%
Revenue growth 5Y1.17%
Sales Q2Q%-30.62%

3.2 Future

COV is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 1.89% yearly.
Based on estimates for the next years, COV will show a small growth in Revenue. The Revenue will grow by 2.09% on average per year.
EPS Next Y7.5%
EPS Next 2Y1.92%
EPS Next 3Y1.89%
EPS Next 5YN/A
Revenue Next Year2.71%
Revenue Next 2Y3.25%
Revenue Next 3Y2.09%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
COV.PA Yearly Revenue VS EstimatesCOV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
COV.PA Yearly EPS VS EstimatesCOV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 11.41, the valuation of COV can be described as very reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of COV indicates a somewhat cheap valuation: COV is cheaper than 71.43% of the companies listed in the same industry.
COV's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.79.
COV is valuated reasonably with a Price/Forward Earnings ratio of 10.61.
COV's Price/Forward Earnings is on the same level as the industry average.
COV is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.38, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.41
Fwd PE 10.61
COV.PA Price Earnings VS Forward Price EarningsCOV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

COV's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of COV is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 14.8
EV/EBITDA 17.23
COV.PA Per share dataCOV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.52
PEG (5Y)N/A
EPS Next 2Y1.92%
EPS Next 3Y1.89%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.88%, COV is a good candidate for dividend investing.
COV's Dividend Yield is a higher than the industry average which is at 7.77.
COV's Dividend Yield is rather good when compared to the S&P500 average which is at 2.51.
Industry RankSector Rank
Dividend Yield 6.88%

5.2 History

The dividend of COV decreases each year by -1.54%.
Dividend Growth(5Y)-1.54%
Div Incr Years1
Div Non Decr Years1
COV.PA Yearly Dividends per shareCOV.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

112.19% of the earnings are spent on dividend by COV. This is not a sustainable payout ratio.
DP112.19%
EPS Next 2Y1.92%
EPS Next 3Y1.89%
COV.PA Yearly Income VS Free CF VS DividendCOV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B
COV.PA Dividend Payout.COV.PA Dividend Payout, showing the Payout Ratio.COV.PA Dividend Payout.PayoutRetained Earnings

COVIVIO

EPA:COV (4/25/2025, 7:00:00 PM)

51

+0.1 (+0.2%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-19 2025-02-19/amc
Earnings (Next)07-21 2025-07-21
Inst Owners40.89%
Inst Owner ChangeN/A
Ins Owners0.2%
Ins Owner ChangeN/A
Market Cap5.69B
Analysts80
Price Target61.96 (21.49%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.88%
Yearly Dividend0.72
Dividend Growth(5Y)-1.54%
DP112.19%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.32%
PT rev (3m)-0.5%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)8.11%
EPS NY rev (3m)9.25%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.29%
Valuation
Industry RankSector Rank
PE 11.41
Fwd PE 10.61
P/S 4.37
P/FCF 14.8
P/OCF 5.81
P/B 0.69
P/tB 0.72
EV/EBITDA 17.23
EPS(TTM)4.47
EY8.76%
EPS(NY)4.81
Fwd EY9.42%
FCF(TTM)3.45
FCFY6.76%
OCF(TTM)8.78
OCFY17.22%
SpS11.66
BVpS73.72
TBVpS70.63
PEG (NY)1.52
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.27%
ROE 0.83%
ROCE 3.52%
ROIC 3.14%
ROICexc 3.24%
ROICexgc 3.29%
OM 61.2%
PM (TTM) 5.23%
GM 76.74%
FCFM 29.56%
ROA(3y)-1.05%
ROA(5y)0.29%
ROE(3y)-3.48%
ROE(5y)0.76%
ROIC(3y)2.97%
ROIC(5y)2.68%
ROICexc(3y)3.08%
ROICexc(5y)2.79%
ROICexgc(3y)3.11%
ROICexgc(5y)2.81%
ROCE(3y)3.32%
ROCE(5y)3%
ROICexcg growth 3Y12.16%
ROICexcg growth 5Y0.31%
ROICexc growth 3Y11.77%
ROICexc growth 5Y0.14%
OM growth 3Y-1.46%
OM growth 5Y-1.11%
PM growth 3Y-61.53%
PM growth 5Y-38.78%
GM growth 3Y-2.18%
GM growth 5Y-0.89%
F-Score7
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 1.14
Debt/FCF 27.72
Debt/EBITDA 10.32
Cap/Depr 519.44%
Cap/Sales 45.79%
Interest Coverage 250
Cash Conversion 107.61%
Profit Quality 564.76%
Current Ratio 0.96
Quick Ratio 0.85
Altman-Z 0.55
F-Score7
WACC5.71%
ROIC/WACC0.55
Cap/Depr(3y)709.28%
Cap/Depr(5y)708.5%
Cap/Sales(3y)50.08%
Cap/Sales(5y)56.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3Y0.91%
EPS 5Y-3.39%
EPS Q2Q%5.69%
EPS Next Y7.5%
EPS Next 2Y1.92%
EPS Next 3Y1.89%
EPS Next 5YN/A
Revenue 1Y (TTM)22.79%
Revenue growth 3Y9.01%
Revenue growth 5Y1.17%
Sales Q2Q%-30.62%
Revenue Next Year2.71%
Revenue Next 2Y3.25%
Revenue Next 3Y2.09%
Revenue Next 5YN/A
EBIT growth 1Y0.7%
EBIT growth 3Y7.42%
EBIT growth 5Y0.05%
EBIT Next Year9.26%
EBIT Next 3Y7.23%
EBIT Next 5YN/A
FCF growth 1Y-28.86%
FCF growth 3YN/A
FCF growth 5Y31.13%
OCF growth 1Y-4.37%
OCF growth 3Y12.5%
OCF growth 5Y4.86%